BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Drug Development

  Neurim Pharmaceuticals Announces Publication Of Positive Effects Of Add-On Circadin® In Alzheimer’s Disease Patients

  June 19, 2014

   · 

  3 min read
• MiMedx Expects To File Its First Investigational New Drug Application In July

  June 19, 2014

   · 

  6 min read
• Drug Development

  Enrollment Continues Into Bio-Path Holdings, Inc. Phase I Clinical Trial

  June 19, 2014

   · 

  1 min read
• Business

  Quintiles, Inc. And Modern Marketing Concepts Collaborate To Launch Innovative Marketing Analytics Platform

  June 19, 2014

   · 

  1 min read
• BioForest

  Allen Institute for Brain Science Release: Researchers Reveal Combinatorial Code For The Developing Brain

  June 19, 2014

   · 

  3 min read
• Business

  James Bartley, MD, PhD; FACMG, Evan Jones, MBA; Matthew Rabinowitz, PhD; And David A.H. Whiteman, MD Elected To ACMG Foundation For Genetic And Genomic Medicine Board Of Directors

  June 19, 2014

   · 

  4 min read
• Business

  VeriTeQ Corporation Appoints Former U.S. Ambassador Ned L. Siegel To Its Board Of Directors

  June 19, 2014

   · 

  1 min read
• Drug Development

  Kala Pharmaceuticals Initiates Phase 3 Clinical Trial for Treatment of Post Surgical Ocular Inflammation and Phase 2 Clinical Trial in Dry Eye

  June 19, 2014

   · 

  4 min read
• Business

  Vernalis PLC And Servier Achieve Research Milestone As BCL-2 Inhibitor Drug Candidate Enters Phase I

  June 19, 2014

   · 

  4 min read
• Drug Development

  Antibe Therapeutics Inc. Receives Approval From Health Canada To Begin Human Clinical Testing

  June 19, 2014

   · 

  1 min read